Cardiovascular Benefits of SGLT2 Inhibitors: A Class Effect?

 
• By John Davis
  
glucometer for glucose level and healthy organic food on a white background. Diabetes concept
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D